PARP-1 Inhibitors In Oncology
Taken from presentations given at the 2013 National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Conference, London 9–10 October.
Epothilones in Breast Cancer Sandra M. Swain, MD December 7, 2005.
